Table 1.
Summary of clinical data of the members in the Chinese Pedigree
| Subjects | Gender | Age of test (yrs) | Age of onset (yrs) | Systolic pressure (mmHg) | Diastolic pressure (mmHg) | IVST, mm(6-12 mm) | ECG | CCr (ml/min) |
|---|---|---|---|---|---|---|---|---|
| II-1 |
M |
63 |
- |
132 |
60 |
10 |
N |
89.1 |
| II-2* |
F |
60 |
50 |
160 |
80 |
12 |
LVH |
81.2 |
| II-3 |
M |
61 |
- |
128 |
68 |
11 |
N |
102.8 |
| II-4 |
F |
58 |
- |
120 |
60 |
10 |
N |
103.5 |
| II-5 |
M |
68 |
- |
124 |
58 |
9 |
N |
87.9 |
| II-6 |
F |
62 |
- |
130 |
60 |
10 |
N |
86.5 |
| II-7 |
M |
70 |
- |
132 |
70 |
10 |
N |
92.6 |
| II-8* |
F |
64 |
55 |
150 |
80 |
12 |
LVH |
72.3 |
| II-9 |
M |
56 |
- |
128 |
64 |
9 |
N |
82.3 |
| II-10 |
F |
52 |
- |
120 |
66 |
11 |
N |
87.4 |
| II-11 |
M |
53 |
- |
124 |
60 |
10 |
N |
92.7 |
| II-12 |
F |
50 |
- |
132 |
68 |
11 |
N |
86.9 |
| II-13* |
M |
54 |
48 |
140 |
100 |
11 |
N |
83.2 |
| II-14 |
F |
50 |
- |
128 |
60 |
9 |
N |
119.2 |
| III-1 |
M |
40 |
- |
130 |
60 |
8 |
N |
122.3 |
| III-2 |
M |
38 |
- |
128 |
58 |
8 |
N |
130.2 |
| III-3 |
F |
35 |
- |
118 |
60 |
9 |
N |
118.6 |
| III-4 |
M |
33 |
- |
120 |
58 |
9 |
N |
108.6 |
| III-5 |
M |
40 |
40 |
150 |
90 |
12 |
N |
89.1 |
| III-6 |
M |
39 |
- |
124 |
60 |
9 |
N |
121.3 |
| III-7 |
F |
44 |
43 |
160 |
90 |
13 |
LVH |
71.2 |
| III-8 |
M |
30 |
- |
116 |
60 |
8 |
N |
114.5 |
| III-9 |
F |
28 |
- |
128 |
70 |
9 |
N |
134.8 |
| III-10 |
M |
28 |
- |
126 |
70 |
9 |
N |
107.9 |
| III-11 |
M |
25 |
- |
130 |
70 |
10 |
N |
126.7 |
| III-12 | F | 27 | - | 120 | 58 | 9 | N | 139.6 |
*These patients received antihypertension treatment. This table shows pretreatment blood pressures. CCr indicates endogenous creatinine clearance; F, female; M, male; IVST, interventricular septal thickness; LVH, ECG showed left ventricular hypertrophy; N, electrocardiography (ECG) was normal.